An epidemiologic study of drug abuse and HIV and AIDS in Malawi by Bisika, T et al.
African Journal of Drug & Alcohol Studies, 7(2), 2008 
Copyright © 2008, CRISA Publications 
AN EPIDEMIOLOGIC STUDY OF DRUG ABUSE AND HIV AND AIDS 
IN MALAWI 
Thomas Bisika,1, 2 Sidon Konyani,2 Immaculate Chamangwana,3
George Khanyizira4
1University of Pretoria, School of Health Systems and Public Health, 2Centre for Social Research, 
University of Malawi, 3Zomba Mental Hospital, Ministry of Health, 4Zomba Central Hospital, 
Ministry of Health 
ABSTRACT 
In this study we examine the prevalence of HIV among drug abusers in Malawi. A purposive 
sample of 200 drug abusers was invited to provide urine and blood samples. The subjects were 
selected from self-presenting drug abusers who visited a district hospital in Malawi. The urine 
samples from both men and women were tested for Gonorrhea and Chlamydia. Urine samples 
from women were also tested for pregnancy. The blood samples were tested for HIV. The study 
found a higher prevalence of HIV among non-injecting drug abusers, with those who abused 
alcohol being more likely to be HIV positive as compared to cannabis abusers. Prevalence of 
sexually transmitted infections (STIs) was, however, low. The main conclusion from this study is 
that drug abuse is a risk factor for HIV and not as much for STIs, even in non-injecting drug 
abusers. 
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INTRODUCTION
More than 40 million people are living 
with HIV worldwide, including 5 million 
new cases in 2005 alone, with Africa 
contributing about 25 million (UNAIDS, 
2006). Malawi is one of the countries 
worst hit by the HIV and AIDS epidemic 
with an infection rate among the 
childbearing age group of 16.4%. Youth 
aged 15-24 claim 46% of new HIV 
infections of which 60% occur among 
girls. It is estimated that about 735,000 
people are sero-positive of which 265,000 
have already developed AIDS (Malawi 
National AIDS Commission, 2003).  
There are three main drugs of abuse 
in Malawi, namely alcohol, cannabis and 
tobacco (cigarettes). The most common 
drug of abuse in Malawi is cannabis. Its 
consumption is growing and production 
had increased from 170,000 hectares in 
1999 to 175,000 in 2000. Cannabis use 
in Malawi is still encouraged by 
traditional beliefs, such as women’s 
belief that cannabis can cure measles, 
some students believe that it can make 
them intelligent and some men think that 
cannabis can improve their sexual 
potency. There has been an increase in 
drug abuse cases in Malawi, from 15% 
in 1995 to 21% in 1999. It has also been 
observed that the problem of drug abuse, 
especially cannabis is increasing among 
the youth resulting in an annual average 
of 20% of registered mental illness cases 
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and other related diseases (Bisika et al, 
2004). 
Drug abuse and addiction have been 
linked with HIV and AIDS since the 
beginning of the epidemic. Although 
injection drug use is well known in this 
regard, the role that non-injection drug 
abuse plays in the spread of HIV is less 
recognized. Drugs have addictive and 
intoxicating effects, which can alter 
judgment and inhibition and lead people to 
engage in impulsive and unsafe behaviors. 
Studies in several countries have shown an 
association between harmful consumption 
of alcohol and health and social 
consequences, including death from road 
traffic accidents, domestic violence, HIV 
infection, and disorders requiring demand 
for treatment (Obot, 2006).  
People typically associate drug abuse 
and HIV and AIDS with injection drug use 
and needle sharing. When injection drug 
users (IDUs) share equipment, such as 
needles, syringes, and other drug injection 
paraphernalia, HIV can be transmitted 
between users. Other infections, such as 
hepatitis C, can also be spread this way. 
Hepatitis C can cause liver disease and 
permanent liver damage. Studies have 
observed that HIV rates are higher among 
Aboriginal IDUs as compared to the 
aboriginal general population (Remis, 
2000) and that IDUs have been pivotal in 
the dynamics of the HIV epidemic (Bastos 
et al, 2002). Studies have also documented 
a serious concentrated HIV epidemic 
among IDUs in countries like Mauritius 
(Abdool et al, 2006). There are, however, 
studies that show that HIV rates obtained 
for IDUs and non injection drug users 
(NIDUs) are fairly similar (Adelekan, 
2006).
Behaviors associated with drug abuse 
are among the main factors in the spread 
of HIV infection. Drugs can change the 
way the brain works through disrupting 
the parts of the brain that people use to 
weigh risks and benefits when making 
decisions (National Institute on Drug 
Abuse, 2007). Poor judgment and risky 
behavior also predisposes drug abusers to 
HIV. Drug abuse by any route (not just 
injection) can put a person at risk for 
contracting HIV because drug and alcohol 
intoxication affect judgment and can lead 
to unsafe sexual practices, which put 
people at risk for contracting HIV or 
transmitting it to others. Studies 
elsewhere have shown that women who 
use crack-cocaine risk HIV transmission 
through unprotected sexual exchange 
(Lichtenstein, 1997). Moreover, many 
women believe that crack-cocaine and 
heroin enhance a man’s sexual desire, 
performance and pleasure and that the 
same drugs are responsible for their 
partner’s abusive and coercive behaviour 
(El-Bassel et al, 2003). 
Biological effects of drug abuse and 
addiction can affect a person's overall 
health, thereby altering susceptibility to 
HIV and progression of AIDS. Drugs of 
abuse and HIV both affect the brain. 
Research has shown that HIV causes 
greater injury to cells in the brain and 
cognitive impairment among 
methamphetamine abusers than among HIV 
patients who do not abuse drugs. In animal 
studies, methamphetamine has been shown 
to increase the amount of HIV in brain cells 
(National Institute on Drug Abuse, 2007). 
However, there are some studies that have 
demonstrated that cannabis does not harm 
the health of the consumers (The Lancet 
Editorial, 1995) while others have 
concentrated on the medical use of cannabis 
among AIDS patients and its potential to 
improve quality of life and health care 
outcomes among patients with HIV and 
AIDS(Prentiss et al, 2004; Ware et al, 
2003). 
The main objective of this study was 
to document the nature and extent of the 
HIV epidemic among drug abusers in 
AN EPIDEMIOLOGIC STUDY OF DRUG ABUSE AND HIV AND AIDS IN MALAWI 
83
Malawi. The specific objectives were to 
identify the actual drugs of abuse and the 
associated method of use, determine the 
prevalence of HIV among drug abusers, 
measure the magnitude of the STI 
problem in drug abusers and document 
the prevalence of pregnancy among 
female drug abusers. 
METHOD
Sampling
As part of a larger HIV and AIDS and 
Drug Abuse assessment study which was 
conducted by the Centre for Social 
Research of the University of Malawi in 
collaboration with the Ministries of 
Health and Home Affairs with funding 
from United Nations Office for Drug 
Control (UNODC), a sample of 200 drug 
abusers was invited to provide urine and 
blood samples. These were selected from 
self-presenting drug abusers who visited a 
district hospital in Malawi in June 2004. 
All the biological specimens were 
collected in Thyolo district located in the 
Southern Region of Malawi. For the 
purposes of this study, besides narcotic 
drugs, cannabis, tobacco and alcohol were 
also included as drugs of abuse and drug 
abuse was defined as the use of any drug 
of abuse at least on a monthly basis.  
Procedures and measurement 
Field workers who were 
undergraduate students were supplied with 
a shoulder cooler bag, specimen 
containers, plastic bag and gloves for 
collection of urine. These field workers 
underwent a one week training which was 
facilitated by a laboratory assistant and a 
registered nurse/midwife. Two of the 
fieldworkers were male while one was 
female. For women, first-voided morning 
specimens were preferred for pregnancy 
testing of maximal hCG concentration, but 
those collected any other time were still 
tested. Each specimen was labeled with the 
subject’s identification number to ensure 
confidentiality. A short questionnaire was 
used to collect drug use, social and 
demographic data. The drugs listed on the 
questionnaire included cannabis, alcohol, 
cocaine, Mandrax, Valium and tobacco. 
The study subjects were asked if they had 
used any drug of abuse in the 30 days 
preceding the survey. Drugs of abuse were 
captured as a multiple-response variable 
which means that a drug abuser could 
mention more than one drug of abuse. 
The urine samples for both men and 
women were tested for Gonorrhea and 
Chlamydia (for women, they were also 
tested for pregnancy). The blood samples 
were tested for HIV. The urine samples 
were sent to University of North Carolina 
(UNC) Laboratory in Lilongwe, Malawi 
where a technician tested them for 
Gonorrhea and Chlamydia using a PCR-
based test. The urine samples from female 
subjects were tested for pregnancy. The 
Betatex Direct Plus Kit, a direct latex 
agglutination test produced by Omega 
Diagnostics Ltd., was used for in-vitro 
detection of hCG in urine. Physical 
condition of pregnancy was indicated by 
positive agglutination with hCG 
concentration of 0.2 IU/ml or higher. A 
rapid diagnostic test called Determine 
was used for HIV testing on the spot. The 
HIV testing was done using the existing 
HIV testing guideline which requires that 
study subjects under the influence of 
drugs should be excluded.  
Data Analysis
Tabulation of the data and further 
analysis was done using the Statistical 
Package for Social Scientists (SPSS) and 
Epi-info.
Ethical Consideration 
All biological specimens were 
collected with full privacy along with the 
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interviews. Bio-specimens did not have 
names indicated, they were labeled by a 
respondent identification number and all 
information collected during the 
interviews was treated as confidential all 
the time. The purpose of the study was 
explained to the participants and the use 
of biological specimens was also clarified 
to the respondents before obtaining a 
verbal informed consent which was 
preferred due to the sensitivity of the 
topic that was being studied. Urine and 
blood was only collected from those 
respondents who agreed. Respondents 
who were under the influence of drugs at 
the time of specimen collection were 
excluded from the study.  
All respondents with STIs were 
treated with a single dose of Ciproflaxin 
(for Gonorrhea in males) and 100 mg of 
Doxycycline taken twice daily for 7 
days for male Chlamydia cases. All 
infected women were supplied with 500 
mg of Erythromycin taken 4 times daily 
for 7 days. All non-infected individuals 
were given a dose of Vitamin C of 500 
mg for 7 days in order to cover those 
who were infected from being 
identified. The District Health Office 
was given the authority to treat the 
patients with STIs using Malawi 
government approved protocols as an 
option. Those who tested positive for 
HIV were offered post-test counseling 
and linked to existing AIDS service 
organizations for on-going counseling 
and treatment. The proposal was 
submitted to National Health Sciences 
Research Committee for ethical review. 
An approval was received on December 
29, 2003 (Ref: 05/5G). 
RESULTS
Socio-demographic background 
Out of the 200 participants 
recruited, 191 were male. With respect 
to age, most of the study subjects were 
in their twenties. The dominant tribe 
was Lomwe (56.0%) followed by 
Mang’anja (20.5%). Most of the 
participants had only primary education 
(129 out of the 200) while 30% had 
secondary education. Only 6 
participants out of the 200 (3%) had 
tertiary education. The study subjects 
were mainly migrant tea estate workers 
(43%) and self employed (28%) and the 
most predominant religion was 
protestant (69%) followed by Catholic 
(21%). Islam accounted for 8% only 
(Table 1). 
Table 1. Social and demographic 
characteristics of the sample (N=200) 
Attribute  Percentage 
Gender   
 Male 95.5 
 Female 4.5 
Age   
 Under 20 3.1 
 20-28 years 46.9 
 29-39 years 27.1 
 40-49 14.2 
 Over 50 years 7.7 
Tribe   
 Lomwe 56.0 
 Mang’anja 20.5 
 Yao 7.0 
 Ngoni 5.0 
 Chewa 4.0 
Religion   
 Protestant 69.3 
 Catholic 20.9 
 Islam 8.4 
Education   
 None 2.3 
 Primary 64.5 
 Secondary 30.2 
 Tertiary 3.0 
Occupation   
 Employed 43.2 
 Business 27.7 
 Farmer 11.3 
 Unemployed 9.8 
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HIV and STI epidemiology 
The overall prevalence rate for HIV 
was 25.5% which was three times higher 
than both the district (7.7%) and almost 
twice national (14.4%) prevalence. The 
drugs of abuse mentioned by the 
participants were cannabis (chamba) 
(81.3%) and alcohol (18.3%). (N=246). 
Methods of use included smoking 
(78.9%), drinking (19.9%) and sniffing 
(1.2%). (N=251). A close look at the HIV 
prevalence rate by type of drug abuse 
revealed that more than a quarter of the 
respondents (25.5%, 95% CI = 20.5-
31.5%) who abused cannabis were sero-
positive while close to a third (31.1%, 
95% CI = 25.2-36.8%) of alcohol abusers 
were positive. This difference was not 
statistically significant using either a 1-
tail or 2-tail Z-test. 
With respect to the method of use, 
more than two thirds (66.7%, N=3) of 
those who reported sniffing were sero-
positive, about a third of those who 
reported drinking as a method of use were 
also sero-positive. More than a quarter of 
those who cited smoking as their mode of 
use were HIV positive. There were no 
injection drug users in the sample. (Table 
2).
Table 2. HIV prevalence among drug 
abusers
Category %Prevalence (95% CI) 
Overall 25.5 (19.5-31.5) 
Cannabis abusers 25.5 (20.5-31.5) 
Alcohol abusers 31.1 (25.2-36.8) 
Method of use  
Sniffing (N=3) 66.7 (Undefined)* 
Drinking 30.4 (24.3-35.7) 
Smoking 25.3 (19.6-30.4) 
*Only three cases reported sniffing 
Although HIV and AIDS awareness 
is almost universal in Malawi, most of the 
drug abusers recruited in this study did 
not know the relationship between drug 
abuse and HIV and AIDS (57.8%). 
With respect to STIs, there was only 
one case of Gonorrhea. This case was 
male and was also an HIV case. Less than 
10% (1 in 9) of the women in the sample 
were pregnant (N=9).
DISCUSSION 
Cannabis (chamba) was the most 
common drug of abuse while smoking 
was the commonest method of use. 
Although there were no injection drug 
users among the study subjects, HIV 
prevalence was much higher among drug 
abusers than in the corresponding general 
population. This means that there was 
indeed an ecological relationship between 
HIV and AIDS and drug abuse, that is, 
HIV and drug abuse thrive in the same 
environment. This is consistent with what 
was found by other researchers in South 
America (Olukoga, 2004). 
Alcohol abusers had an excess risk 
for HIV as compared to Cannabis
(chamba) abusers. This could be due to 
the fact that alcohol is imbibed in places 
where prostitutes transact their business. 
It must be noted, however, that both 
alcohol and Cannabis (chamba) abusers 
had a heightened risk for HIV and AIDS. 
Most of the participants did not know the 
relationship between HIV and AIDS and 
drug abuse. It is, therefore, very important 
to highlight the ecological relationship 
between drug abuse and HIV infection in 
national HIV and AIDS prevention and 
sensitization campaigns. 
No injecting drug abusers were in the 
sample. This shows that high sero-
prevalence is not only associated with 
injecting drugs use. Thus drug abuse by 
any route (not just injection) can put a 
person at risk for getting HIV. This 
finding is not at variance with what was 
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concluded in a study conducted in 
Nigeria8. The results obtained on STI 
prevalence does not support the direct 
linkage of STIs and drug abuse but 
underscores the fact that drug abusers 
have a higher risk for HIV than STIs. 
This inverse relation was also observed in 
another study which concluded that 
higher socioeconomic status was a risk 
factor for HIV-1 infection but not for 
STIs (Dallabetta et al, 1993). Since our 
study was conducted at a health facility, 
further population based research is 
required to investigate the low prevalence 
of STIs among drug abusers as this might 
mean that most of them are not seeking 
treatment from hospitals. 
The major limitation of this study was 
the small representation of women and 
youth which has implications on the 
representativeness of sample and hence 
external validity of the findings. The 
other problem was that data on marital 
status was not collected and it was, 
therefore, not possible to control for 
marital status as a confounding factor. 
Similarly the researchers did not collect 
information on risk factors and sexual 
behaviour. These could have helped to 
further explain the findings. 
CONCLUSION 
A higher HIV prevalence was observed 
among non injecting drug abusers as 
compared to the district and national 
prevalence. The prevalence of STIs 
was, however, low. This indicates that 
non injecting drug use is a risk factor 
for HIV but not STIs. While HIV and 
AIDS awareness remains high in the 
general population, the low knowledge 
regarding the linkage between drug 
abuse and HIV and AIDS requires an 
intervention of a public health nature 
including targeting drug abusers in VCT 
campaigns. 
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